课题基金 / 基金详情

Nanodelivery systems for targeted inhibition of DNA repair in the treatment of unresectable lung cancer

Nanodelivery systems for targeted inhibition of DNA repair in the treatment of unresectable lung cancer
用于靶向抑制 DNA 修复的纳米递送系统治疗不可切除的肺癌
批准号:
380733
负责人:
Lavasanifar Afsaneh
金额:
$37.62万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2018
资助国家:
加拿大
项目状态:
已结题
起止时间:
2018-03-01 至 2021-09-01

项目摘要

项目成果

Lavasanifar Afsaneh的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Lung cancer is the second most common cancer in both men and women and the number one cause of cancer related death in North America. Lung cancer is rarely detected at the early stages of disease because symptoms tend to be mild and non-specific. When dia
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeted delivery of novel inhibitors of DNA repair and combination treatments for the modulation of therapeutic response against metastatic colorectal cancer
  • 批准号:
    443665
  • 项目类别:
    Operating Grants
  • 资助金额:
    $47.65万
  • 财政年份:
    2021
  • 负责人:
    Lavasanifar Afsaneh
  • 依托单位:
Nanodelivery Systems for Modulation of Chemotherapy Response in Invasive and Metastatic Breast Cancer
  • 批准号:
    313994
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2014
  • 负责人:
    Lavasanifar Afsaneh
  • 依托单位:
Tumor targeted polymeric nanocarriers for oncogene silencing therapy of metastatic breast cancer
  • 批准号:
    259926
  • 项目类别:
    Operating Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2012
  • 负责人:
    Lavasanifar Afsaneh
  • 依托单位:
Ligand guided polymeric nano-carriers for tumor targeted drug and oncogene silencing therapy: A strategy for chemosensitization of resistant cancers
  • 批准号:
    231826
  • 项目类别:
    Operating Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2011
  • 负责人:
    Lavasanifar Afsaneh
  • 依托单位:
海外基金